Tech Company Financing Transactions

one.bio Funding Round

On 12/12/2024, one.bio raised $27 million in Series A investment from Alpha Edison, Acre Venture Partners and Collaborative Fund.

Transaction Overview

Company Name
Announced On
12/12/2024
Transaction Type
Venture Equity
Amount
$27,000,000
Round
Series A
Proceeds Purpose
Proceeds will be invested in getting products on the shelf and bringing more fibers to market (it's already identified several thousand).

Company Information

Company Status
Private & Independent
Industry
FoodTech
Mailing Address
231 G Street 24
Davis, CA 95616
USA
Phone
Undisclosed
Email Address
Not Recorded
Overview
one.bio is a fast-paced, emerging biotechnology spinout from UC Davis creating ingredients for food and biopharmaceutical applications. We use proprietary technology to create novel oligosaccharides from natural products, with a focus on producing ingredients that beneficially modulate the microbiome and immune function.
Profile
one.bio LinkedIn Company Profile
Social Media
one.bio Company Twitter Account
Company News
one.bio News
Facebook
one.bio on Facebook
YouTube
one.bio on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Matt Barnard
  Matt Barnard LinkedIn Profile  Matt Barnard Twitter Account  Matt Barnard News  Matt Barnard on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/12/2024: Terradot venture capital transaction
Next: 12/12/2024: Azimuth AI venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to record every notable VC transaction. All VC database entries on this site come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary